The American Journal of Sports Medicine
Manuscript Submission Guidelines:
The editor of AJSM, Bruce Reider, can be contacted via email at breider@ajsm.org.
The American Journal of Sports Medicine (AJSM) is the official publication of the American Orthopaedic Society for Sports Medicine.
Submit manuscripts online at https://submit.ajsm.org.
Download the AJSM Submission Guidelines or see below.
Download the AJSM Ethics Policies.
AJSM offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway. Please note that the SAGE Choice article processing charge for AJSM is $4,000 USD.
1. Manuscript Submission Guidelines
Manuscripts must not be under simultaneous consideration by any other publication, before or during the peer-review process and cannot be uploaded to any preprint server. Papers presented at AOSSM meetings must be submitted to the Journal for first rights of refusal. Articles published in AJSM may not be published elsewhere without written permission from the publisher.
Manuscripts should cite any other work by one or more of the co-authors that is relevant to the subject matter of the current submission or that used any of the same subjects, animals, or specimens being reported in the current submission. This includes manuscripts that are currently under preparation, are being considered by journals, are accepted for publication, or already published. In any of these cases, the relationship to the current submission should be made clear.
All review articles (such as systematic review, meta-analysis) submitted will be considered for the Current Concepts section. Authors with ideas for current concepts should contact the associate editor, Timothy Foster, MD, to find out if AJSM has recently published a review article on that topic or if there is a similar submission in progress. Contact Dr. Foster at CurrentConcepts@ajsm.org to inquire about your idea or submit already completed papers directly to the journal at https://submit.ajsm.org.
2. Submissions
Authors should register on our online submission site and link and verify their ORCID ID (see information below) at https://submit.ajsm.org to submit manuscripts.
When manuscripts have been received by the editorial office, the corresponding author will be sent an acknowledgment giving an assigned manuscript number, which should be used with all subsequent correspondence for anything related to that particular manuscript.
The following items are required on submission:
Blinded manuscript including the abstract and any tables and figures where they occur in the text. No identifying information should appear in the uploaded manuscript. Please remove author names, initials, and institutions. State or country names may be used, but do not include specific locations such as cities or regions.
Journal Contributor Publishing Agreement and AJSM Author Disclosure Statement. These forms are available for download from the author area of the submission site. The corresponding author must complete the forms and return them to AJSM by email or upload them online as a PDF or Word file using the ‘‘upload legal documents’’ option. As an alternative to the AJSM disclosure form, authors may submit the ICMJE disclosure form (please access the form using Internet Explorer) along with the AJSM Supplemental Form available on our website.The AOSSM checks author disclosures against the Open Payments Database (https:// openpaymentsdata.cms.gov). Any combined payments listed over $500/year from a single company should be included. Authors should include payments from the previous 5 years
A copy of the IRB or other agency approval (or waiver) if animal subjects or human subjects or tissues or health information were used. Please see further instructions under "Text." This information should be uploaded with the disclosure and publishing forms and not as a supplemental file.
Requirements for specific study types:
Randomized Controlled Trials. All clinical trials started after January 1, 2016 must prospectively registered at ClinicalTrials.gov or a similar database recognized by the ICMJE to be considered for publication. See list of ICMJE acceptable registries at http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/.The original study protocol for all registered clinical trials must be included and can be uploaded as a supplemental file. This information should be blinded for peer review (remove author name and location as well as trial registration number). The protocol information from the registration site or the formal protocol for the study design are acceptable. Use of a CONSORT flow diagram is required to illustrate the grouping and flow of patients for all randomized clinical trials. The CONSORT checklist must also be completed and uploaded as a supplemental file.
Observational Studies. Cohort, case-control, or cross-sectional studies should include the CONSORT flow diagram in the paper. The STROBE checklist must also be completed and uploaded as a supplemental file.
Biologics Studies. Studies reporting the use of autologous blood-based therapies (such as platelet-rich plasma, autologous conditioned serum, autologous protein solution) or cell-based therapies (including autologous cells derived from bone marrow or adipose tissue and allogeneic cells) should include the Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) checklist uploaded as a supplemental file.
Animal Studies. Studies involving live animals models should include the completed ARRIVE Guidelines checklist as a supplemental file.
3. Authors
Authors may be asked to supply full supporting data for their study. If the author refuses this request, the paper will be rejected without further review. Cover letter, acknowledgments, and suggested reviewers are optional. If a paper has more than 5 authors, a cover letter detailing the contributions of all authors should be included in the appropriate box on the submission page. Only those involved in writing the paper should be included in the author line. Others should be listed as a footnote or acknowledgment. While there is no limit on the number of authors, no more than 12 will be listed on the masthead of the published article; additional authors will be listed at the end of the article. These authors will be indexed in Index Medicus as full authors.
We strongly encourage all authors of the paper to link their ORCID ID to their accounts in our online submission system. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name. Corresponding authors should confirm whether their coauthors would like to add an ORCID ID before submitting their manuscript to the journal. If your manuscript is accepted for publication, you will not be able to add an ORCID ID after the manuscript is sent to our production team. If you do not already have an ORCID ID please follow this link to create one.
4. Manuscript Formats
Manuscript pages should be double-spaced with consecutive page numbers and continuous line numbers. The abstract should be included with the manuscript as well as being entered in the Metadata section (except for case reports, which do not require abstracts). Manuscripts should be 6000 words or fewer (including abstract and references). There are also limitations on figures, tables, and references; see guidelines below. The system handles most common word processing formats; however, Word is preferred.
4. Manuscript Preparation
4.1 Abstract
Abstracts should summarize the contents of the article in 350 words or less. The abstract should be structured in the following format:
Background: In one or two sentences, summarize the scientific body of knowledge surrounding your study and how this led to your investigation.
Hypothesis/Purpose: State the theory(ies) that you are attempting to prove or disprove by your study or the purpose if no hypothesis exists.
Study Design: Identify the overall design of your study. See list below.
Methods: Succinctly summarize the overall methods you used in your investigation. Include the study population, type of intervention, method of data collection, and length of the study.
Results: Report the most important results of your study. Only include positive results that are statistically significant, or important negative results that are supported by adequate power. Report actual data, not just P values.
Conclusion: State the answer to your original question or hypothesis. Summarize the most important conclusions that can be directly drawn from your study.
Clinical Relevance: If yours was a laboratory study, describe its relevance to clinical sports medicine.
Key Terms: Include at least 4 key terms for indexing. When submitting an article, you will be asked to choose from a list of terms that are used for assigning reviewers. These terms can be used in the manuscript as well. The list can be found at https://submit.ajsm.org/submission/editexpertise.
What is known about the subject: Please state what is currently known about this subject to place your study in perspective for the reviewers.
What this study adds to existing knowledge: Please state what this study adds to the existing knowledge.
The last two items are for reviewers only and are not included in the word count, but should appear at the end of the abstract in the uploaded text.
4.2 Study Designs
Meta-analysis: A systematic overview of studies that pools results of two or more studies to obtain an overall answer to a question or interest. Summarizes quantitatively the evidence regarding a treatment, procedure, or association.
Systematic Review: An article that examines published material on a clearly described subject in a systematic way. There must be a description of how the evidence on this topic was tracked down, from what sources and with what inclusion and exclusion criteria.
Randomized Controlled Clinical Trial: A group of patients is randomized into an experimental group and a control group. These groups are followed up for the variables / outcomes of interesilart. NOTE: All clinical trials started after January 1, 2016 must be prospectively registered at ClinicalTrials.gov or a similar database recognized by the ICMJE to be considered for publication. See list of ICMJE-acceptable registries at http://www.icmje.org/about-icmje/ faqs/clinical-trials-registration/
Crossover Study Design: The administration of two or more experimental therapies one after the other in a specified or random order to the same group of patients.
Cohort Study: Involves identification of two groups (cohorts) of patients, one which did receive the exposure of interest, and one which did not, and following these cohorts forward for the outcome of interest.
Case-Control Study: A study that involves identifying patients who have the outcome of interest (cases) and patients without the same outcome (controls), and looking back to see if they had the exposure of interest.
Cross-Sectional Study: The observation of a defined population at a single point in time or time interval. Exposure and outcome are determined simultaneously.
Case Series: Describes characteristics of a group of patients with a particular disease or who have undergone a particular procedure. Design may be prospective or retrospective. No control group is used in the study, although the discussion may compare the results to other published outcomes.
Case Report: Similar to the case series, except that only one or a small group of cases is reported.
Descriptive Epidemiology Study: Observational study describing the injuries occurring in a particular sport.
Controlled Laboratory Study: An in vitro or in vivo investigation in which 1 group receiving an experimental treatment is compared to 1 or more groups receiving no treatment or an alternate treatment.
Descriptive Laboratory Study: An in vivo or in vitro study that describes characteristics such as anatomy, physiology, or kinesiology of a broad range of subjects or a specific group of interest. Authors should choose the design that best fits the study.
The Editor will make the final determination of the study design and level of evidence based on the Center for Evidence Based Medicine guidelines.
……
更多详情：
https://journals.sagepub.com/author-instructions/AJS
